BioCryst meets late-stage study goal, but falls short of competition - BioPharma Dive https://t.co/1EQmL9HPvE — IDRO (@IDROOhio) May 22, 2019
BioCryst meets late-stage study goal, but falls short of competition - BioPharma Dive https://t.co/1EQmL9HPvE
No comments:
Post a Comment